Table 1

Factors related to intraprocedural events that were considered in the univariate analysis

FactorsIPR(+)
(n=221)
Ischemia(+)
(n=226)
Rebleeding(+)
(n=63)
All
(n=5358)
Age64.7±15.665.1±14.169.8±15.064.6±14.9
Sex
 Female174 (4.6%)153 (4.0%)48 (1.3%)3794
 Male46 (3.0%)72 (4.6%)15 (1.0%)1558
mRS before onset
 0171 (4.1%)171 (4.1%)46 (1.1%)4221
 118 (4.8%)17 (4.5%)7 (1.9%)378
 29 (4.1%)13 (5.9%)2 (0.9%)219
 36 (4.3%)8 (5.7%)1 (0.7%)141
 49 (6.31%)4 (2.8%)5 (3.5%)144
 53 (2.8%)5 (4.7%)0 (0.0%)106
WFNS classification
 145 (3.8%)59 (5.0%)4 (0.3%)1179
 264 (4.3%)82 (5.5%)16 (1.1%)1490
 333 (4.4%)29 (3.8%)12 (1.6%)757
 440 (4.2%)30 (3.2%)18 (1.9%)948
 535 (4.1%)20 (2.4%)13 (1.5%)850
Site
 AcomA, ACA89 (5.3%)61 (3.6%)23 (1.4%)1674
 PcomA48 (3.6%)51 (3.8%)7 (0.5%)1352
 Distal ICA12 (3.9%)19 (6.2%)3 (1.0%)306
 Proximal ICA8 (2.4%)16 (4.8%)6 (1.8%)334
 MCA13 (3.8%)18 (5.3%)5 (1.5%)338
 BA28 (3.5%)33 (4.1%)15 (1.9%)796
 VA, PCA18 (4.2%)22 (5.2%)2 (0.5%)427
Size (mm)
 <333 (7.7%)15 (3.5%)8 (1.2%)429
 3–581 (4.6%)55 (3.1%)12 (0.7%)1747
 5–753 (3.5%)50 (3.3%)20 (1.3%)1502
 7–1035 (3.6%)50 (5.1%)10 (1.0%)972
 10–2517 (2.6%)52 (7.9%)12 (1.8%)655
 ≥200 (0.0%)2 (1.8%)0 (0.0%)11
Shape
 Small size/small neck109 (4.4%)69 (2.8%)14 (0.6%)2452
 Small size/wide neck92 (4.4%)95 (4.6%)35 (1.7%)2071
 Large16 (2.6%)47 (7.5%)11 (1.8%)624
 Giant0 (0.0%)2 (1.7%)0 (0.0%)12
 Non-saccular3 (2.7%)11 (10.0%)2 (1.8%)110
Surgery
 Scheduled8 (1.7%)25 (5.3%)3 (0.6%)476
 Emergent212 (4.3%)201 (4.1%)60 (1.2%)4877
Anesthesia
 General193 (4.0%)205 (4.2%)53 (1.1%)4861
 Local28 (5.8%)21 (4.3%)9 (1.9%)486
Day of treatment
 Within 24 hours170 (4.6%)147 (4.0%)48 (1.3%)3716
 Within 72 hours30 (3.9%)34 (4.4%)9 (1.2%)767
 Within 7 days7 (2.4%)18 (6.1%)3 (1.0%)297
 Within 14 days4 (2.7%)10 (6.8%)2 (1.4%)148
 Within 30 days6 (4.3%)3 (2.1%)1 (0.7%)141
 After 30 days3 (1.3%)13 (5.8%)0 (0.0%)223
Angiography system used
 Single plane45 (3.7%)56 (4.6%)16 (1.3%)1210
 Bi-plane176 (4.3%)169 (4.1%)47 (1.2%)4084
3D rotational angiography
 Used201 (4.1%)214 (4.4%)59 (1.2%)4871
 Not used20 (4.8%)11 (2.6%)4 (1.0%)417
Treatment strategy
 Simple107 (3.7%)96 (3.3%)33 (1.1%)2911
 Double catheter12 (3.5%)18 (5.2%)3 (0.9%)343
 Balloon-assisted92 (5.2%)77 (4.4%)22 (1.2%)1761
 Stent-assisted9 (3.3%)33 (12.0%)5 (1.8%)274
Coil
 Bare platinum only215 (4.2%)211 (4.1%)61 (1.2%)5099
 Hydrocoil(+)6 (3.2%)13 (7.0%)2 (1.1%)187
Result of occlusion
 CO112 (4.1%)86 (3.2%)16 (0.6%)2723
 NR79 (4.1%)98 (5.1%)30 (1.6%)1911
 BF26 (4.0%)40 (6.1%)17 (2.6%)652
Heparin administration
 After sheath154 (3.9%)158 (4.0%)49 (1.2%)3932
 After guiding catheter12 (4.6%)14 (5.4%)5 (1.9%)261
 After first coil29 (4.2%)37 (5.4%)7 (1.0%)688
 None16 (5.6%)8 (2.8%)1 (0.3%)288
Preop antiplatelet drugs
 Yes24 (3.1%)48 (6.2%)10 (1.3%)770
 No190 (4.3%)171 (3.9%)52 (1.2%)4376
  • *Statistically significant.

  • ACA, anterior cerebral artery; AcomA, anterior communicating artery; AT, attempt; BA, basilar artery; BF, body filling; CO, complete occlusion; ICA, internal carotid artery;IPR, intraprocedural rupture; MCA, middle cerebral artery; mRS, modified Rankin Scale; NR, neck remnant; PAO, parent artery occlusion; PCA, posterior cerebral artery; PcomA, posterior communicating artery; Preop, preoperative; VA, vertebral artery; WFNS, World Federation of Neurosurgical Societies.